U.S. Stock News

Global Medical REIT (GMRE) has posted a turnaround, moving into profitability as net profit margins improved and earnings climbed by an average of 16.9% per year over the past five years. Looking ahead, earnings are forecast to accelerate by 22.6% per year, outpacing the broader US market's expected 16% growth. However, projected revenue growth of 2.9% per year lags market averages. A one-off gain of $6.8 million played a notable role in the latest results, so investors will want to keep an...

Summit Hotel Properties (INN) remains unprofitable, with net profit margins showing no improvement over the last year. Despite the lack of accelerated profit growth, the company has reduced its losses over the past five years at a steady annual rate of 66.5%. Revenue is forecast to rise by 2.1% each year, which trails well behind the broader US market’s 10.5% pace. For value-focused investors, shares trading at $5.27, well below the estimated fair value of $17.75, create an intriguing setup...

Rigel Pharmaceuticals (RIGL) has turned profitable in the last year, with net profits reversing after a string of losses. The company’s earnings grew at an impressive 40.2% per year over the past five years, signaling high quality performance. However, forward guidance calls for a 4% annual decline in earnings over the next three years and revenue growth of just 6.5% per year, falling short of the US market’s 10.5% average. Despite upbeat profit growth, the outlook now turns on whether Rigel...

Mosaic (MOS) delivered remarkable earnings growth of 284% over the last year, a sharp turnaround from its five-year average decline of -8.4% per year. Net profit margins strengthened significantly, moving from 2% to 8.4%. However, this surge was driven in part by a one-off $652.2 million gain, making some of these earnings non-recurring. Looking ahead, sentiment will weigh Mosaic’s low Price-to-Earnings Ratio of 8.9x and pricing below analyst fair value estimates against the forecast for...

Postal Realty Trust (PSTL) delivered a net profit margin of 10.4%, a substantial leap from last year’s 2.7%, as robust earnings fueled a 377.6% jump in growth over the past year. The company has built a five-year track record of consistent profitability gains and, looking forward, earnings are projected to grow at roughly 10% annually with revenue forecast to rise 11.5% per year, ahead of the general US market. Investors are weighing these strong margin improvements and sustained profit...

Latham Group (SWIM) is currently unprofitable, with expectations to turn profitable within the next three years. Earnings are forecast to grow quickly at 46.36% per year, significantly outpacing the broader market. Revenue is projected to rise by 4.8% per year, which is a much slower pace than the US market's 10.5%. The company has steadily reduced its losses by an annual rate of 13.7% over the past five years. While the Price-to-Sales Ratio sits well above industry peers at 1.6x, shares are...

Axon Enterprise (AXON) posted eye-catching forecasts, with revenue expected to grow 21.6% annually, significantly outpacing the broader US market’s 10.5% rate. EPS is also projected to rise sharply by 55.2% per year. However, the company’s net profit margin slipped to 13.6% from 16.2% last year, and its most recent annual earnings growth of 11.3% is below its five-year average of 59.9%. The results also include a sizable one-off gain of $197.6 million, which complicates the assessment of the...

Navitas Semiconductor (NVTS) is forecasting standout growth, with revenue expected to rise 26.6% per year. This is more than double the broader US market’s 10.5% annual pace. Despite that top-line momentum, the company remains unprofitable, with losses having deepened at a rate of 22.5% per year over the past five years and no signs yet of margins improving. Investors now face the lure of rapid revenue growth, weighed against persistent unprofitability and the stock’s hefty valuation premium...

Finance of America Companies (FOA) reported losses that have deepened at a 15.4% annual rate over the past five years, while net profit margin remains under pressure, there are some positives for investors. While GAAP earnings for Q3 2025 came in at -$29 million, Adjusted Net Income (ANI) was $33 million, reflecting the exclusion of non-cash fair-value changes and other non-recurring items that management does not believe are representative of core operations...

International General Insurance Holdings (NasdaqCM:IGIC) reported steady profitability with EPS growth averaging 30.9% annually over the past five years. Net profit margin improved to 23.3% from last year’s 22.6%, while earnings for the past year rose 13.2%, trailing its five-year trend. At a share price of $22.46, the stock trades well below the estimated fair value of $30.41. IGIC’s price-to-earnings ratio of 7.8x is also well under both industry and peer averages. With no risks highlighted...

Ultragenyx Pharmaceutical (RARE) continues to operate at a loss, with net losses growing at a rate of 14.8% per year over the past five years and no improvement in profit margins. Despite these persistent losses, revenue is forecast to climb 28.5% per year and earnings are set to jump 81.24% annually, with expectations for RARE to reach profitability within three years. The stock is trading at $31.87, notably below its estimated fair value of $361.43, positioning it as potentially undervalued...

Clearway Energy (CWEN.A) posted a net profit margin of 5.3%, a decline from last year’s 7.2%. Average earnings growth over the past five years has been just 1.2% per year, but the most recent results show negative year-over-year earnings growth. Looking ahead, earnings are forecast to grow at an impressive 23.1% annually, which is well ahead of the US market average. Revenue is expected to rise 9.6% per year, slightly lagging the broader market. Investors face mixed signals as the stock...

Entravision Communications (EVC) continues to struggle with profitability, posting net losses that have widened over the past five years at an annual rate of 69.7%. The company’s net profit margin shows no sign of improvement while it remains unprofitable, and recent earnings trends do not offer any evidence that profit growth has picked up. The data highlights mounting risks for investors, with high and rising losses overshadowing any potential rewards at this stage. See our full analysis...

Flywire (FLYW) has posted a sharp turnaround, swinging to profitability with net profit margins improving over the last year and earnings growing at an impressive 40.3% per year for the past five years. While the company registered a sizable one-off loss of $6.5 million for the twelve months ending September 30, 2025, revenue is projected to increase at 13.7% per year and earnings are forecast to soar 68.1% per year, both comfortably ahead of US market averages. These trends highlight a...

Vertex Pharmaceuticals (VRTX) is forecasting revenue growth of 8.8% annually, trailing the broader US market’s 10.5% pace. Earnings are expected to rise 13.3% per year, slower than the US average of 16%. Over the past five years, the company’s earnings have actually declined by 10.4% per year, yet Vertex recently moved into profitability and has improved its net profit margins. This puts a spotlight on ongoing improvements in earnings quality this season. See our full analysis for Vertex...

Jackson Financial (JXN) posted a net loss, with losses having deepened at a rate of 14.3% per year over the past five years. Looking ahead, analysts project revenue growth of 2.4% per year and earnings growth of 5.68% annually, with JXN expected to reach profitability within the next three years. For investors, these figures signal that the current unprofitability may be a temporary challenge. A turnaround could be on the horizon as earnings are forecast to improve. See our full analysis for...

V2X (VVX) delivered a breakout year on the bottom line, with net profit margins climbing to 1.8% from just 0.2% last year. Although earnings had trended down over the last five years (declining 4.9% per year), the most recent year saw an astonishing 798.1% earnings growth. Investors will note that while revenue is expected to grow at a more modest 4.3% annually, VVX's solid price-to-earnings ratio and strengthening margins highlight a sharp turnaround in profitability. See our full analysis...

XPLR Infrastructure (XIFR) saw losses deepen at an average rate of 44% per year over the past five years, with no improvement in its net profit margin and no record of high-quality earnings. Revenue is projected to grow 3% annually, which is notably slower than the broader US market’s 10.5% expected annual pace. However, earnings are forecast to rise at a robust 38.82% per year, and the company is expected to reach profitability within three years. Investors have a clear catalyst to watch...

Eversource Energy (ES) posted a nuanced set of financial results as reported in its latest filings. Over the past five years, earnings have declined at an average rate of 24.8% per year. However, the company managed to return to profitability in the most recent year, aided by the effects of a non-recurring $764.7 million loss that weighed on the quality of reported EPS. While revenue is forecast to grow at 5.3% per year and annual earnings growth is estimated at 6.13%, both figures trail the...

Allegiant Travel (ALGT) remains in the red, posting losses that have deepened at an average rate of 19.8% per year over the past five years, with no improvement in its net profit margin over the last year. Even so, analysts are calling for a dramatic turnaround, forecasting earnings growth of 99.56% per year and expecting the company to become profitable within three years. This pace outstrips average market growth. Revenue, meanwhile, is expected to rise 5.3% per year. See our full analysis...

NGL Energy Partners (NGL) remains unprofitable, with no available forecasts for earnings or revenue growth. However, it has managed to narrow its losses by 36% annually over the past five years. Despite the absence of earnings, NGL’s Price-to-Sales ratio of 0.3x is notably below both the US Oil and Gas industry average of 1.5x and the peer average of 1.1x. This indicates the stock is valued attractively on its sales multiples. The market price of $8.57 currently sits above the $2.71 fair...

Crescent Energy (CRGY) is forecasting exceptionally strong earnings growth of 58% per year, leaving the US market’s 16% growth prediction far behind. However, revenue is only expected to rise at 8.9% annually, trailing the broader market’s 10.5% pace. Net profit margin has dropped to 0.7% from 2.2% last year after a one-off $38.5 million loss took a bite out of profitability. The numbers set up a compelling mix of robust future earnings potential, offset by real concerns about recent margin...

Curious if Sociedad Química y Minera de Chile’s shares are a bargain right now? You’re not alone in wondering whether this is a can’t-miss value play or a stock to watch from the sidelines. Lately, the stock has seen some major momentum, jumping 10.2% over the last month and notching a remarkable 32.0% gain year-to-date, although longer-term returns remain in the red over three years. Recent news continues to put SQM into the spotlight, with analysts and investors weighing both opportunities...

Day One Biopharmaceuticals (DAWN) is still reporting losses, but over the past five years, the company has steadily narrowed those losses at a rate of 0.1% per year. With future revenue expected to climb 30.6% annually and earnings forecast to rise a substantial 86.63% per year, DAWN is projected to become profitable within three years. This pace stands out compared to the broader US market. Investors will likely see this combination of robust growth expectations and a share price trading...